Document is current
Any future updates will be listed below
-
Authors
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (81901712, 82271981)
Sichuan Science and Technology Program (2021YFS0175)
Sichuan Province Science and Technology Support Program (2022NSFSC0735)
Youth Innovation Research Project of Sichuan Medical Association (Q21012)
Chinese Society of Clinical Oncology (HFCSC2019B01)
- License Information
-
More Information
Article History
Received: 18 November 2022
Accepted: 25 August 2023
First Online: 5 September 2023
Declarations
:
: This prospective study was approved by the Institutional Review Board (IRB) and completed the clinical trial registration (registration number: ChiCTR2200055651; ). The requirement for informed consent was acquired from patients’ legal guardians.
: Not applicable.
: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
